Comparative effectiveness research in chronic obstructive pulmonary disease
- PMID: 23105965
- PMCID: PMC3479302
- DOI: 10.2217/cer.11.10
Comparative effectiveness research in chronic obstructive pulmonary disease
Abstract
Chronic obstructive pulmonary disease affects millions worldwide. It is America's third leading cause of death, and results in significant morbidity and cost. Although many therapies exist and are being developed to alleviate symptoms and decrease morbidity and mortality in chronic obstructive pulmonary disease, most have only been studied in placebo-controlled efficacy studies in highly selected populations. Comparative effectiveness and translational research in chronic obstructive pulmonary disease will require the development of infrastructures to support collaboration between researchers and the stakeholders who generate, disseminate and use new knowledge. Methodologies need to evolve to both prioritize research questions and to conduct collaborative comparative effectiveness research studies. Given the impracticality of testing every clinical intervention in comparative pragmatic trials for comparative effectiveness research in chronic obstructive pulmonary disease, we advocate expanding methodology that includes the use of observational databases with serially performed effectiveness analyses and quasi-experimental designs that include following healthcare changes longitudinally over time to assess benefit, harm, subgroups and cost.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.Am J Respir Crit Care Med. 2013 Feb 1;187(3):320-6. doi: 10.1164/rccm.201206-0994WS. Epub 2012 Nov 15. Am J Respir Crit Care Med. 2013. PMID: 23155144 Free PMC article.
-
Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.Clin Pharmacol Ther. 2011 Dec;90(6):888-92. doi: 10.1038/clpt.2011.237. Epub 2011 Nov 2. Clin Pharmacol Ther. 2011. PMID: 22048220
-
Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.Trials. 2014 May 1;15:153. doi: 10.1186/1745-6215-15-153. Trials. 2014. PMID: 24885672 Free PMC article. Clinical Trial.
-
The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation.Health Technol Assess. 2015 Oct;19(81):1-246. doi: 10.3310/hta19810. Health Technol Assess. 2015. PMID: 26470875 Free PMC article. Review.
Cited by
-
Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial.Ann Am Thorac Soc. 2023 Dec;20(12):1743-1751. doi: 10.1513/AnnalsATS.202305-458OC. Ann Am Thorac Soc. 2023. PMID: 37769182 Clinical Trial.
-
Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2017 Dec;14(12):1836-1843. doi: 10.1513/AnnalsATS.201706-453OC. Ann Am Thorac Soc. 2017. PMID: 28825846 Free PMC article.
-
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.Am J Respir Crit Care Med. 2015 Aug 15;192(4):500-14. doi: 10.1164/rccm.201506-1082ST. Am J Respir Crit Care Med. 2015. PMID: 26278796 Free PMC article.
-
Evaluating Comparative Effectiveness Research Priorities for Care Coordination in Chronic Obstructive Pulmonary Disease: A Community-Based eDelphi Study.JMIR Res Protoc. 2015 Aug 12;4(3):e103. doi: 10.2196/resprot.4591. JMIR Res Protoc. 2015. PMID: 26268741 Free PMC article.
-
Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs.Chronic Obstr Pulm Dis. 2015;2(1):70-80. doi: 10.15326/jcopdf.2.1.2014.0148. Chronic Obstr Pulm Dis. 2015. PMID: 25927076 Free PMC article.
References
-
- Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16. - PubMed
-
- Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare. MEDPAC; Washington, DC, USA: 2007.
-
- Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010;7(3):214–228. - PubMed
-
- Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903. - PubMed
-
- Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD. 2006;3(4):211–218. - PubMed
Websites
-
- [Accessed 27 August 2011];NHLBI morbidity and mortality chartbook. www.nhlbi.nih.gov/resources/docs/cht-book.htm.
-
- [Accessed 27 August 2011];FASTSTATS: chronic lower respiratory disease. www.cdc.gov/nchs/fastats/copd.htm.
-
- HCUP nationwide inpatient sample (NIS) Healthcare cost and utilization project (HCUP) 2000–2006. Agency for Healthcare Research and Quality; Rockville, MD, USA: www.hcup-us.ahrq.gov/nisoverview.jsp. - PubMed
-
- [Accessed 21 June 2011];HCUPnet: a tool for identifying, tracking, and analyzing national hospital statistics. http://hcupnet.ahrq.gov.
-
- [Accessed 21 June 2011];Global strategy for the diagnosis, management and prevention of COPD: global initiative for chronic obstructive lung disease (GOLD) www.goldcopd.org.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical